BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260301
DTEND;VALUE=DATE:20260330
DTSTAMP:20260427T224207
CREATED:20260115T052211Z
LAST-MODIFIED:20260116T004427Z
UID:10000235-1772323200-1774828799@melanoma.org.au
SUMMARY:Melanoma March 2026
DESCRIPTION:Melanoma March events are being held across Australia for the 15th year to raise awareness and help save lives from melanoma. \nMelanoma Institute Australia (MIA) is proudly celebrating 15 years of Melanoma March in 2026\, and is calling on all Australians to either join a local march or host their own event to take steps to help save lives from melanoma. \nNow open for registrations\, MIA’s Melanoma March events will be held all across the country during March 2026 and are organised by volunteer committees impacted by melanoma. \nThe events provide an opportunity for patients and families to come together to support each other and remember those lost to the disease. \nMelanoma is the deadliest form of skin cancer and Australia has the highest melanoma rates in the world. One person is diagnosed with melanoma every 30 minutes and one person dies from the disease every six hours. It is the most common cancer affecting 20-39-year-old Australians. \nFunds raised during Melanoma March 2026 will support life-saving research. \nWorld-class research by MIA has led to groundbreaking treatment advances and improved patient outcomes. First came targeted drug therapies\, followed closely by immunotherapies – the ‘penicillin moment for cancer treatment’ – and now neoadjuvant (pre-surgery) immunotherapy. Close to 60% of advanced melanoma patients are now surviving and are essentially cured because of these treatments. \nFind your local event via the button below. If there is not an event in your area\, or if you can’t attend an event\, you can still support the campaign by getting creative and hosting a March Your Way activity with friends or individually – or by making a donation. \nRegister at the link below before 1 February to receive 50% off! \nREGISTER NOW OR DONATECost to Register: \nCosts to attend a physical event are: \n\nAdults (over 18 years) $40\nChild (5-17 years) $20\nChild (under 5) Free\nFamily deal: Register 2 x Adults and up to 5 Children (5-17 yrs) for $80. Additional adults will be charged the full rate.\n\nRegistrations to March Your Way are half price!
URL:https://melanoma.org.au/event/melanoma-march-2026/
CATEGORIES:Fundraiser,Awareness
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/MIAF0240-MM26-MIA-website-tile-1200-x-675.jpg
ORGANIZER;CN="Melanoma Institute Australia":MAILTO:events@melanoma.org.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260309T170000
DTEND;TZID=Australia/Sydney:20260309T170000
DTSTAMP:20260427T224207
CREATED:20260203T032013Z
LAST-MODIFIED:20260203T032013Z
UID:10000246-1773075600-1773075600@melanoma.org.au
SUMMARY:Rising Tide Clinical Cancer Research Program
DESCRIPTION:RTFCCR invites academic institutions and not-for-profit organizations to collaborate on innovative\, patient-centered clinical trials. Our mission is to improve cancer patients’ treatment options and quality of life by funding studies focused on detection\, treatment\, and implementation. \nWe support phase I to phase III interventional clinical trials but do not fund basic research\, phase IV trials\, or observational studies. Funding is available to institutions worldwide where effective grant oversight is feasible. \nSubmission Criteria \n\nThe interventional clinical trial can be an early—to—late—stage clinical trial (Phase 1\, 2\, and 3) with a patient partner involvement in the study protocol design.\nOnly applications aimed at detecting and intervening in early cancer (pre-cancerous changes) can also be considered at the pre-clinical validation stage.\nPharmaceutical agents used in the study can be generic (off-patent repurposing)\, registered for this indication\, or under development by an academic institution.\nClinical trials testing immunotherapies should be discussed with RTFCCR before application submission.\nFinal selection will be contingent on scientific review\, strategic portfolio fit\, and availability of funds\n\nKey Dates \nApplication deadlines: 9 March\, 22 June and 23 November 2026 \nSEE FUNDING GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/rising-tide-research-program/
CATEGORIES:Clinical Trial Cohorts,Grants
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/RisingTide600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260309T170000
DTEND;TZID=Australia/Sydney:20260309T170000
DTSTAMP:20260427T224207
CREATED:20260210T034150Z
LAST-MODIFIED:20260210T034150Z
UID:10000251-1773075600-1773075600@melanoma.org.au
SUMMARY:Sydney Cancer Partners SERCI Grant
DESCRIPTION:SCP Small Equipment and Research Capacity Building Infrastructure (SERCI) Grant \nThe objective is to support SCP members to complete internationally competitive translational cancer research projects by improving access to specialised research equipment or software. \nApplicants may request funds to purchase equipment\, software or software licenses with a total purchase cost of up to $50K (excluding GST). There is no minimum cost request. Equipment/software purchased under this scheme must be located and/or accessed at a Sydney Health Partners member institution. \nKey Dates \nScheme Open: 9 February 2026  \nScheme Close: 5 pm\, 9 March 2026 \nNotification of outcomes: 10 April 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/scp-serci-grant/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/Sydney_Cancer_Partners-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR